CDP 870 anti-cytokine antibody fragment: CTP began Phase II ascending dose testing

Celltech Group plc (LSE:CTP), Slough, U.K.
Product: CDP

Read the full 83 word article

How to gain access

Continue reading with a
two-week free trial.